SCCA–IgM baseline of patients who developed HCC were significantly higher than patients who did not during the same follow-up period, especially in HCV-infected patients, and positivity of SCCA–IgM at baseline was associated with a significantly shorter HCC-free survival [64]. Here, CD40LG is linked to hepatocellular carcinoma.